Cargando…

Managing Multi-center Flow Cytometry Data for Immune Monitoring

With the recent results of promising cancer vaccines and immunotherapy1–5, immune monitoring has become increasingly relevant for measuring treatment-induced effects on T cells, and an essential tool for shedding light on the mechanisms responsible for a successful treatment. Flow cytometry is the c...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Scott, Laske, Karoline, Welters, Marij JP, Bidmon, Nicole, van der Burg, Sjoerd H, Britten, Cedrik M, Enzor, Jennifer, Staats, Janet, Weinhold, Kent J, Gouttefangeas, Cécile, Chan, Cliburn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463798/
https://www.ncbi.nlm.nih.gov/pubmed/26085786
http://dx.doi.org/10.4137/CIN.S16346
_version_ 1782375839320506368
author White, Scott
Laske, Karoline
Welters, Marij JP
Bidmon, Nicole
van der Burg, Sjoerd H
Britten, Cedrik M
Enzor, Jennifer
Staats, Janet
Weinhold, Kent J
Gouttefangeas, Cécile
Chan, Cliburn
author_facet White, Scott
Laske, Karoline
Welters, Marij JP
Bidmon, Nicole
van der Burg, Sjoerd H
Britten, Cedrik M
Enzor, Jennifer
Staats, Janet
Weinhold, Kent J
Gouttefangeas, Cécile
Chan, Cliburn
author_sort White, Scott
collection PubMed
description With the recent results of promising cancer vaccines and immunotherapy1–5, immune monitoring has become increasingly relevant for measuring treatment-induced effects on T cells, and an essential tool for shedding light on the mechanisms responsible for a successful treatment. Flow cytometry is the canonical multi-parameter assay for the fine characterization of single cells in solution, and is ubiquitously used in pre-clinical tumor immunology and in cancer immunotherapy trials. Current state-of-the-art polychromatic flow cytometry involves multi-step, multi-reagent assays followed by sample acquisition on sophisticated instruments capable of capturing up to 20 parameters per cell at a rate of tens of thousands of cells per second. Given the complexity of flow cytometry assays, reproducibility is a major concern, especially for multi-center studies. A promising approach for improving reproducibility is the use of automated analysis borrowing from statistics, machine learning and information visualization21–23, as these methods directly address the subjectivity, operator-dependence, labor-intensive and low fidelity of manual analysis. However, it is quite time-consuming to investigate and test new automated analysis techniques on large data sets without some centralized information management system. For large-scale automated analysis to be practical, the presence of consistent and high-quality data linked to the raw FCS files is indispensable. In particular, the use of machine-readable standard vocabularies to characterize channel metadata is essential when constructing analytic pipelines to avoid errors in processing, analysis and interpretation of results. For automation, this high-quality metadata needs to be programmatically accessible, implying the need for a consistent Application Programming Interface (API). In this manuscript, we propose that upfront time spent normalizing flow cytometry data to conform to carefully designed data models enables automated analysis, potentially saving time in the long run. The ReFlow informatics framework was developed to address these data management challenges.
format Online
Article
Text
id pubmed-4463798
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-44637982015-06-17 Managing Multi-center Flow Cytometry Data for Immune Monitoring White, Scott Laske, Karoline Welters, Marij JP Bidmon, Nicole van der Burg, Sjoerd H Britten, Cedrik M Enzor, Jennifer Staats, Janet Weinhold, Kent J Gouttefangeas, Cécile Chan, Cliburn Cancer Inform Original Research With the recent results of promising cancer vaccines and immunotherapy1–5, immune monitoring has become increasingly relevant for measuring treatment-induced effects on T cells, and an essential tool for shedding light on the mechanisms responsible for a successful treatment. Flow cytometry is the canonical multi-parameter assay for the fine characterization of single cells in solution, and is ubiquitously used in pre-clinical tumor immunology and in cancer immunotherapy trials. Current state-of-the-art polychromatic flow cytometry involves multi-step, multi-reagent assays followed by sample acquisition on sophisticated instruments capable of capturing up to 20 parameters per cell at a rate of tens of thousands of cells per second. Given the complexity of flow cytometry assays, reproducibility is a major concern, especially for multi-center studies. A promising approach for improving reproducibility is the use of automated analysis borrowing from statistics, machine learning and information visualization21–23, as these methods directly address the subjectivity, operator-dependence, labor-intensive and low fidelity of manual analysis. However, it is quite time-consuming to investigate and test new automated analysis techniques on large data sets without some centralized information management system. For large-scale automated analysis to be practical, the presence of consistent and high-quality data linked to the raw FCS files is indispensable. In particular, the use of machine-readable standard vocabularies to characterize channel metadata is essential when constructing analytic pipelines to avoid errors in processing, analysis and interpretation of results. For automation, this high-quality metadata needs to be programmatically accessible, implying the need for a consistent Application Programming Interface (API). In this manuscript, we propose that upfront time spent normalizing flow cytometry data to conform to carefully designed data models enables automated analysis, potentially saving time in the long run. The ReFlow informatics framework was developed to address these data management challenges. Libertas Academica 2015-06-10 /pmc/articles/PMC4463798/ /pubmed/26085786 http://dx.doi.org/10.4137/CIN.S16346 Text en © 2014 the author(s), publisher and licensee Libertas Academica Limited This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.
spellingShingle Original Research
White, Scott
Laske, Karoline
Welters, Marij JP
Bidmon, Nicole
van der Burg, Sjoerd H
Britten, Cedrik M
Enzor, Jennifer
Staats, Janet
Weinhold, Kent J
Gouttefangeas, Cécile
Chan, Cliburn
Managing Multi-center Flow Cytometry Data for Immune Monitoring
title Managing Multi-center Flow Cytometry Data for Immune Monitoring
title_full Managing Multi-center Flow Cytometry Data for Immune Monitoring
title_fullStr Managing Multi-center Flow Cytometry Data for Immune Monitoring
title_full_unstemmed Managing Multi-center Flow Cytometry Data for Immune Monitoring
title_short Managing Multi-center Flow Cytometry Data for Immune Monitoring
title_sort managing multi-center flow cytometry data for immune monitoring
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463798/
https://www.ncbi.nlm.nih.gov/pubmed/26085786
http://dx.doi.org/10.4137/CIN.S16346
work_keys_str_mv AT whitescott managingmulticenterflowcytometrydataforimmunemonitoring
AT laskekaroline managingmulticenterflowcytometrydataforimmunemonitoring
AT weltersmarijjp managingmulticenterflowcytometrydataforimmunemonitoring
AT bidmonnicole managingmulticenterflowcytometrydataforimmunemonitoring
AT vanderburgsjoerdh managingmulticenterflowcytometrydataforimmunemonitoring
AT brittencedrikm managingmulticenterflowcytometrydataforimmunemonitoring
AT enzorjennifer managingmulticenterflowcytometrydataforimmunemonitoring
AT staatsjanet managingmulticenterflowcytometrydataforimmunemonitoring
AT weinholdkentj managingmulticenterflowcytometrydataforimmunemonitoring
AT gouttefangeascecile managingmulticenterflowcytometrydataforimmunemonitoring
AT chancliburn managingmulticenterflowcytometrydataforimmunemonitoring